Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H31NO |
| Molecular Weight | 229.402 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCC[N+](C)(C)[O-]
InChI
InChIKey=SYELZBGXAIXKHU-UHFFFAOYSA-N
InChI=1S/C14H31NO/c1-4-5-6-7-8-9-10-11-12-13-14-15(2,3)16/h4-14H2,1-3H3
| Molecular Formula | C14H31NO |
| Molecular Weight | 229.402 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Lauramine Oxide is a tertiary amine oxide. Because Lauramine Oxide has dual functional groups in the same molecule (both asidic and basic groups), it is very versatile. At a concentration of 30%, Lauramine Oxide produced severe dermal reactions in rabbits, but at 0.3% only slight to moderate erythema with slight edema. Lauramine Oxide at 0.1% in drinking water was not carcinogenic in rats. Lauramine oxide is used mainly in hair-care products such as shampoos, hair rinses, tonics and hair-grooming aids.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pycnogenol and Ginkgo biloba extract: effect on peroxynitrite-oxidized sarcoplasmic reticulum Ca-ATPase. | 2010-12 |
|
| Complexation of phenol and thiophenol by amine N-oxides: isothermal titration calorimetry and ab initio calculations. | 2010-11-15 |
|
| Effect of nanoparticle size on the morphology of adsorbed surfactant layers. | 2010-04-01 |
|
| Backbone and ILV side chain methyl group assignments of the integral human membrane protein VDAC-1. | 2010-04 |
|
| Two different hematocrit detection methods: different methods, different results? | 2010-03-09 |
|
| Reflections on my career in analytical chemistry and biochemistry. | 2010 |
|
| Structure and non-essential function of glycerol kinase in Plasmodium falciparum blood stages. | 2009-01 |
|
| Structural characterization of recombinant human CD81 produced in Pichia pastoris. | 2008-02 |
|
| Theoretical predictions of the coordination of water to the polar headgroup of dimethyldodecylamine-N-oxide. | 2007-03-12 |
|
| Overexpression and purification of the RyR1 pore-forming region. | 2007 |
|
| Hydration of dimethyldodecylamine-N-oxide: enthalpy and entropy driven processes. | 2006-07-13 |
|
| Purification, crystallization, and properties of F1-ATPase complexes from the thermoalkaliphilic Bacillus sp. strain TA2.A1. | 2005-11 |
|
| Thermodynamic study of the protonation of dimethyldodecylamine N-oxide micelles in aqueous solution at 298 K. Establishment of a theoretical relationship linking critical micelle concentrations and pH. | 2004-09-28 |
|
| The ionic track in the F1-ATPase from the thermophilic Bacillus PS3. | 2004-03-09 |
|
| Resolution of the V1 ATPase from Manduca sexta into subcomplexes and visualization of an ATPase-active A3B3EG complex by electron microscopy. | 2003-01-03 |
|
| The (alpha F(357)C)(3)(beta R(372)C)(3)gamma subcomplex of the F(1)-ATPase from the thermophilic Bacillus PS3 has altered ATPase activity after cross-linking alpha and beta subunits at noncatalytic site interfaces. | 2002-03-05 |
|
| Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A. | 1999-04-27 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:35:01 GMT 2025
by
admin
on
Mon Mar 31 17:35:01 GMT 2025
|
| Record UNII |
4F6FC4MI8W
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C014518
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
1364388
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | RxNorm | ||
|
216-700-6
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
DB04147
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
LAURYLDIMETHYLAMINE OXIDE
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
DTXSID1020514
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
15433
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
SUB21624
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
131762
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
4F6FC4MI8W
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
5451
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
4F6FC4MI8W
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
1643-20-5
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY | |||
|
100000088316
Created by
admin on Mon Mar 31 17:35:01 GMT 2025 , Edited by admin on Mon Mar 31 17:35:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
